AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda Pharmaceutical Company Limited TAK. The Japanese drug maker will use Iambic's AI drug ...
Since 1997, Discovery Mood & Anxiety Program has been helping thousands of patients build the confidence and skills they need to better navigate life’s challenges. We look at the person, not the ...
TOKYO, Oct. 8, 2024 /PRNewswire/ -- Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, "Ciconia") today announced its establishment as a joint venture company based on a ...
SAN DIEGO--(BUSINESS WIRE)--Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances ...
PARIS & LONDON--(BUSINESS WIRE)--Aqemia announces it is broadening and accelerating its computational platform to target RNAs using its physics-enabled generative AI engine. Building on successes in ...
Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make an equity investment in Aitia as part of the ...
Scientific progress often stalls not because of a lack of ideas, but because of a lack of material. Across drug discovery, agriculture, and industrial biotech, promising programs are delayed or ...
CU Science Discovery high school programs build connections between university science and the broader community. Through authentic, hands-on experiences with CU researchers, these programs spark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results